This invention is useful for treatment of diabetes using encapsulated cells. The invention consists of one independent claim that appears to cover a method for treating diabetes by administration of encapsulated cells that have a specific set of biological and physical properties. The cells appear to be a type of intermediatery cell, or a progenitor cell that is capable of expansion.
It is known that endothelial cell dysfunction is one of the major causes of morbidity and mortality in the Western world. For example, if endothelium could properly respond to the hypoxic conditions associated with cardiac angina and form new blood vessels, then heart disease would take such a heavy toll on today’s society. This is just a limited example, atherosclerosis, various tissue...
This patent teaches the generation of neurons from culturing of whole bone marrow in basic fibroblast growth factor and epidermal growth factor. This patent may be useful as a simple and easy to generate source of cells for therapy of neurodegenerative diseases.
This is a composition of matter patent covering polypeptide sequences for "Stem cell-Derived Neuron Survival Factors" (SDNSF). The polypeptides appear to be secretory and to represent natural factors that induce neural stem cell self-renewal and differentiation. In the examples section the inventors treated neurospheres with SDNSF and demonstrated increased number of...
This patent is from the same group that originally patented embryonic stem cells of human. In the current patent there is one independent claim that covers the differentiation of human embryonic stem cells into neural progenitor cells. The method claims involves culturing so that embryoid bodies are formed from the embryonic stem cells through incubation with
Dendritic cells are the most potent stimulators of the immune system, having the unique ability to activate naive T cells. Thus dendritic cells are of great interest in terms of immune stimulatory approaches for treatment of cancer and viral diseases. On the flip side of the coin, dendritic cells are known to have the ability of...
This patent teaches how to generate corneal epithelium in vitro from stem cell sources.
This patent covers the treatment of a "proliferative disorder" using a family of compounds which include N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-4-piperazin-1-- ylmethyl-benzamide methanesulfonate. These agents inhibit stem cell factor signalling, as well as signalling of PDGF.
This patent covers a 2 step method of generating insulin producing cells.
According to the first issued claim, the initial step involves obtaining what essentially appears to be a mesenchymal stem cell (adherent cell positive for CD44, CD90 and CD71, negative for monocyte and hematopoietic markers, CD11b and CD45, respectively) and culturing them with an antioxidant in order to generate...
Dendritic cells are the most potent stimulators of the immune system. Generally it is the dendritic cell that picks up antigens and makes the decision whether the immune system should "get mad" and go after the antigen, or whether the antigen represents no substantial danger and therefore should be ignored. In some cases the dendritic...